Insider transactions

EDGAR

TRAVERE THERAPEUTICS, INC.

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-22.

Open-market purchases (code P)
0 transactions, — shares
Open-market sales (code S)
118 transactions, 2,127,271 shares
Sum of shares × price per share: 110,398,142.5995

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 291

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-10-15 Filed 2026-10-19Dube Eric M Director · Officer: CHIEF EXECUTIVE OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)43,73526.88
1,175,596.8

Derived: shares × price per share. Exact value 1175596.80.

476,621Direct (D) Yes— Open filing 0001763494-26-000008 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-19Dube Eric M Director · Officer: CHIEF EXECUTIVE OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)200,0008.93
1,786,000

Derived: shares × price per share. Exact value 1786000.00.

676,621Direct (D) Yes— Open filing 0001763494-26-000008 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-19Dube Eric M Director · Officer: CHIEF EXECUTIVE OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)128,06552.9672
6,783,244.468

Derived: shares × price per share. Exact value 6783244.4680.

548,556Direct (D) Yes
F1, F2
  • F1 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F2 The weighted average sale price for the transaction reported was $52.9672, and the range of prices were between $52.63 and $53.6250. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001763494-26-000008 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-19Dube Eric M Director · Officer: CHIEF EXECUTIVE OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)37,27054.1997
2,020,022.819

Derived: shares × price per share. Exact value 2020022.8190.

511,286Direct (D) Yes
F1, F3
  • F1 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F3 The weighted average sale price for the transaction reported was $54.1997, and the range of prices were between $53.63 and $54.62. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001763494-26-000008 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-19Dube Eric M Director · Officer: CHIEF EXECUTIVE OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)78,40055.0179
4,313,403.36

Derived: shares × price per share. Exact value 4313403.3600.

432,886Direct (D) Yes
F1, F4
  • F1 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F4 The weighted average sale price for the transaction reported was $55.0179, and the range of prices were between $54.63 and $55.57. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001763494-26-000008 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-19Dube Eric M Director · Officer: CHIEF EXECUTIVE OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee stock option (right to buy) — underlying Common Stock (43,735) — exercise price 26.88
Disposed (D)43,7350—168,925Direct (D) Yes
F5
  • F5 The stock option is fully vested and exercisable.
Open filing 0001763494-26-000008 Read from the filing’s XML Dispute this row
2026-10-15 Filed 2026-10-19Dube Eric M Director · Officer: CHIEF EXECUTIVE OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee stock option (right to buy) — underlying Common Stock (200,000) — exercise price 8.93
Disposed (D)200,0000—160,000Direct (D) Yes
F6
  • F6 One-fourth of the shares subject to the stock option vested and became exercisable on January 31, 2025, and the remaining shares vest in 36 equal monthly installments thereafter.
Open filing 0001763494-26-000008 Read from the filing’s XML Dispute this row
2026-09-17 Filed 2026-09-17Heerma Peter Officer: EVP, CHIEF COMMERCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)8,28222.40
185,516.8

Derived: shares × price per share. Exact value 185516.80.

125,348Direct (D) Yes— Open filing 0001789617-26-000004 Read from the filing’s XML Dispute this row
2026-09-17 Filed 2026-09-17Heerma Peter Officer: EVP, CHIEF COMMERCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)8,28265.0709
538,917.1938

Derived: shares × price per share. Exact value 538917.1938.

117,066Direct (D) Yes
F2, F9
  • F2 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F9 The weighted average sale price for the transaction reported was $65.0709, and the range of prices were between $65.00 and $65.14. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001789617-26-000004 Read from the filing’s XML Dispute this row
2026-09-17 Filed 2026-09-17Heerma Peter Officer: EVP, CHIEF COMMERCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee stock option (right to buy) — underlying Common Stock (8,282) — exercise price 22.40
Disposed (D)8,2820—44,837Direct (D) Yes
F11
  • F11 One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of January 31, 2023, and the remaining shares vest in 36 equal monthly installments thereafter.
Open filing 0001789617-26-000004 Read from the filing’s XML Dispute this row
2026-09-17 Filed 2026-09-17Dube Eric M Director · Officer: CHIEF EXECUTIVE OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)108,49323.34
2,532,226.62

Derived: shares × price per share. Exact value 2532226.62.

541,379Direct (D) Yes— Open filing 0001763494-26-000007 Read from the filing’s XML Dispute this row
2026-09-17 Filed 2026-09-17Dube Eric M Director · Officer: CHIEF EXECUTIVE OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)101,69164.5866
6,567,875.9406

Derived: shares × price per share. Exact value 6567875.9406.

439,688Direct (D) Yes
F1, F7
  • F1 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F7 The weighted average sale price for the transaction reported was $64.5866, and the range of prices were between $63.84 and $64.83. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001763494-26-000007 Read from the filing’s XML Dispute this row
2026-09-17 Filed 2026-09-17Dube Eric M Director · Officer: CHIEF EXECUTIVE OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)6,80264.9508
441,795.3416

Derived: shares × price per share. Exact value 441795.3416.

432,886Direct (D) Yes
F1, F8
  • F1 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F8 The weighted average sale price for the transaction reported was $64.9508, and the range of prices were between $64.84 and $65.14. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001763494-26-000007 Read from the filing’s XML Dispute this row
2026-09-17 Filed 2026-09-17Dube Eric M Director · Officer: CHIEF EXECUTIVE OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee stock option (right to buy) — underlying Common Stock (108,493) — exercise price 23.34
Disposed (D)108,4930—0Direct (D) Yes
F9
  • F9 The stock option is fully vested and exercisable.
Open filing 0001763494-26-000007 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17ROTE WILLIAM E. Officer: Chief Research Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)35017.96
6,286

Derived: shares × price per share. Exact value 6286.00.

98,547Direct (D) Yes— Open filing 0001698262-26-000005 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17ROTE WILLIAM E. Officer: Chief Research Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)55,00015.46
850,300

Derived: shares × price per share. Exact value 850300.00.

153,547Direct (D) Yes— Open filing 0001698262-26-000005 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17ROTE WILLIAM E. Officer: Chief Research Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)57,50026.88
1,545,600

Derived: shares × price per share. Exact value 1545600.00.

211,047Direct (D) Yes— Open filing 0001698262-26-000005 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17ROTE WILLIAM E. Officer: Chief Research Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)65,10463.1205
4,109,397.032

Derived: shares × price per share. Exact value 4109397.0320.

145,943Direct (D) Yes
F2, F6
  • F2 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F6 The weighted average sale price for the transaction reported was $63.1205, and the range of prices were between $62.47 and $63.4650. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001698262-26-000005 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17ROTE WILLIAM E. Officer: Chief Research Officer
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)47,74663.6126
3,037,247.1996

Derived: shares × price per share. Exact value 3037247.1996.

98,197Direct (D) Yes
F2, F7
  • F2 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F7 The weighted average sale price for the transaction reported was $63.6126, and the range of prices were between $63.47 and $63.96. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001698262-26-000005 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17ROTE WILLIAM E. Officer: Chief Research Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee stock option (right to buy) — underlying Common Stock (350) — exercise price 17.96
Disposed (D)3500—0Direct (D) Yes
F8
  • F8 The stock option is fully vested and exercisable.
Open filing 0001698262-26-000005 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17ROTE WILLIAM E. Officer: Chief Research Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee stock option (right to buy) — underlying Common Stock (55,000) — exercise price 15.46
Disposed (D)55,0000—0Direct (D) Yes
F8
  • F8 The stock option is fully vested and exercisable.
Open filing 0001698262-26-000005 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17ROTE WILLIAM E. Officer: Chief Research Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee stock option (right to buy) — underlying Common Stock (57,500) — exercise price 26.88
Disposed (D)57,5000—0Direct (D) Yes
F8
  • F8 The stock option is fully vested and exercisable.
Open filing 0001698262-26-000005 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17Heerma Peter Officer: EVP, CHIEF COMMERCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)100,00011.25
1,125,000

Derived: shares × price per share. Exact value 1125000.00.

217,066Direct (D) Yes— Open filing 0001789617-26-000004 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17Heerma Peter Officer: EVP, CHIEF COMMERCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)55,00015.46
850,300

Derived: shares × price per share. Exact value 850300.00.

272,066Direct (D) Yes— Open filing 0001789617-26-000004 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17Heerma Peter Officer: EVP, CHIEF COMMERCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)17,71726.88
476,232.96

Derived: shares × price per share. Exact value 476232.96.

289,783Direct (D) Yes— Open filing 0001789617-26-000004 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17Heerma Peter Officer: EVP, CHIEF COMMERCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)93,60463.2471
5,920,181.5484

Derived: shares × price per share. Exact value 5920181.5484.

196,179Direct (D) Yes
F2, F7
  • F2 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F7 The weighted average sale price for the transaction reported was $63.2471, and the range of prices were between $62.50 and $63.49. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001789617-26-000004 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17Heerma Peter Officer: EVP, CHIEF COMMERCIAL OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)79,11363.6546
5,035,906.3698

Derived: shares × price per share. Exact value 5035906.3698.

117,066Direct (D) Yes
F2, F8
  • F2 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F8 The weighted average sale price for the transaction reported was $63.6546, and the range of prices were between $63.50 and $64.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001789617-26-000004 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17Heerma Peter Officer: EVP, CHIEF COMMERCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee stock option (right to buy) — underlying Common Stock (100,000) — exercise price 11.25
Disposed (D)100,0000—0Direct (D) Yes
F10
  • F10 The stock option is fully vested and exercisable.
Open filing 0001789617-26-000004 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17Heerma Peter Officer: EVP, CHIEF COMMERCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee stock option (right to buy) — underlying Common Stock (55,000) — exercise price 15.46
Disposed (D)55,0000—0Direct (D) Yes
F10
  • F10 The stock option is fully vested and exercisable.
Open filing 0001789617-26-000004 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17Heerma Peter Officer: EVP, CHIEF COMMERCIAL OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee stock option (right to buy) — underlying Common Stock (17,717) — exercise price 26.88
Disposed (D)17,7170—500Direct (D) Yes
F10
  • F10 The stock option is fully vested and exercisable.
Open filing 0001789617-26-000004 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17Dube Eric M Director · Officer: CHIEF EXECUTIVE OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)195,84123.34
4,570,928.94

Derived: shares × price per share. Exact value 4570928.94.

628,727Direct (D) Yes— Open filing 0001763494-26-000007 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17Dube Eric M Director · Officer: CHIEF EXECUTIVE OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)99,71663.2593
6,307,964.3588

Derived: shares × price per share. Exact value 6307964.3588.

529,011Direct (D) Yes
F1, F5
  • F1 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F5 The weighted average sale price for the transaction reported was $63.2593, and the range of prices were between $62.51 and $63.505. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001763494-26-000007 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17Dube Eric M Director · Officer: CHIEF EXECUTIVE OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)96,12563.6389
6,117,289.2625

Derived: shares × price per share. Exact value 6117289.2625.

432,886Direct (D) Yes
F1, F6
  • F1 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F6 The weighted average sale price for the transaction reported was $63.6389, and the range of prices were between $63.51 and $64.01. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001763494-26-000007 Read from the filing’s XML Dispute this row
2026-09-16 Filed 2026-09-17Dube Eric M Director · Officer: CHIEF EXECUTIVE OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee stock option (right to buy) — underlying Common Stock (195,841) — exercise price 23.34
Disposed (D)195,8410—108,493Direct (D) Yes
F9
  • F9 The stock option is fully vested and exercisable.
Open filing 0001763494-26-000007 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Calvin Sandra Officer: SVP, CHIEF ACCOUNTING OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)2,50027.50
68,750

Derived: shares × price per share. Exact value 68750.00.

44,853Direct (D) Yes— Open filing 0001882909-26-000004 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Calvin Sandra Officer: SVP, CHIEF ACCOUNTING OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)1,25022.4
28,000

Derived: shares × price per share. Exact value 28000.0.

46,103Direct (D) Yes— Open filing 0001882909-26-000004 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Calvin Sandra Officer: SVP, CHIEF ACCOUNTING OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)1,62520.46
33,247.5

Derived: shares × price per share. Exact value 33247.50.

47,728Direct (D) Yes— Open filing 0001882909-26-000004 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Calvin Sandra Officer: SVP, CHIEF ACCOUNTING OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)4,27562.135
265,627.125

Derived: shares × price per share. Exact value 265627.125.

43,453Direct (D) Yes
F1, F2
  • F1 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F2 The weighted average sale price for the transaction reported was $62.135, and the range of prices were between $61.53 and $62.51. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001882909-26-000004 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Calvin Sandra Officer: SVP, CHIEF ACCOUNTING OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)80062.8481
50,278.48

Derived: shares × price per share. Exact value 50278.4800.

42,653Direct (D) Yes
F1, F3
  • F1 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F3 The weighted average sale price for the transaction reported was $62.8481, and the range of prices were between $62.62 and $63.19. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001882909-26-000004 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Calvin Sandra Officer: SVP, CHIEF ACCOUNTING OFFICER
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)30063.6633
19,098.99

Derived: shares × price per share. Exact value 19098.9900.

42,353Direct (D) Yes
F1, F4
  • F1 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F4 The weighted average sale price for the transaction reported was $63.6633, and the range of prices were between $63.64 and $63.71. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001882909-26-000004 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Calvin Sandra Officer: SVP, CHIEF ACCOUNTING OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee stock option (right to buy) — underlying Common Stock (2,500) — exercise price 27.50
Disposed (D)2,5000—0Direct (D) Yes
F5
  • F5 The stock option is fully vested and exercisable.
Open filing 0001882909-26-000004 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Calvin Sandra Officer: SVP, CHIEF ACCOUNTING OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee stock option (right to buy) — underlying Common Stock (1,250) — exercise price 22.40
Disposed (D)1,2500—3,750Direct (D) Yes
F6
  • F6 One-fourth of the shares subject to the stock option vested and became exercisable on the first anniversary of January 31, 2023, and the remaining shares vest in 36 equal monthly installments thereafter.
Open filing 0001882909-26-000004 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Calvin Sandra Officer: SVP, CHIEF ACCOUNTING OFFICER
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee stock option (right to buy) — underlying Common Stock (1,625) — exercise price 20.46
Disposed (D)1,6250—17,875Direct (D) Yes
F7
  • F7 One-fourth of the shares subject to the stock option vested and become exercisable on the first anniversary of January 31, 2025, and the remaining shares vest in 36 equal monthly installments thereafter.
Open filing 0001882909-26-000004 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Inrig Jula Officer: EVP, Head of RD CMO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)32,3958.93
289,287.35

Derived: shares × price per share. Exact value 289287.35.

145,165Direct (D) Yes— Open filing 0001902368-26-000008 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Inrig Jula Officer: EVP, Head of RD CMO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)25,39062.0167
1,574,604.013

Derived: shares × price per share. Exact value 1574604.0130.

119,775Direct (D) Yes
F1, F2
  • F1 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F2 The weighted average sale price for the transaction reported was $62.0167, and the range of prices were between $61.40 and $62.39. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001902368-26-000008 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Inrig Jula Officer: EVP, Head of RD CMO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)17,28462.6242
1,082,396.6728

Derived: shares × price per share. Exact value 1082396.6728.

102,491Direct (D) Yes
F1, F3
  • F1 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F3 The weighted average sale price for the transaction reported was $62.6242, and the range of prices were between $62.40 and $63.365. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001902368-26-000008 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Inrig Jula Officer: EVP, Head of RD CMO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)1,60063.6850
101,896

Derived: shares × price per share. Exact value 101896.0000.

100,891Direct (D) Yes
F1, F4
  • F1 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
  • F4 The weighted average sale price for the transaction reported was $63.685, and the range of prices were between $63.58 and $63.86. Upon request by the SEC staff, the Issuer, or any security holder of the Issuer, full information regarding the number of shares sold at each price will be provided.
Open filing 0001902368-26-000008 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Inrig Jula Officer: EVP, Head of RD CMO
S

Open market or private sale of non-derivative or derivative security

Common Stock
Disposed (D)40065.31
26,124

Derived: shares × price per share. Exact value 26124.00.

100,491Direct (D) Yes
F1
  • F1 This sale was made pursuant to a written plan adopted on June 16, 2026, meeting the requirements of Rule 10b5-1(c) of the Securities Exchange Act of 1934, as amended.
Open filing 0001902368-26-000008 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17Inrig Jula Officer: EVP, Head of RD CMO
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Employee stock option (right to buy) — underlying Common Stock (32,395) — exercise price 8.93
Disposed (D)32,3950—43,605Direct (D) Yes
F5
  • F5 One-fourth of the shares subject to the stock option vest and become exercisable on the first anniversary of January 31, 2024, and the remaining shares vest in 36 equal monthly installments thereafter.
Open filing 0001902368-26-000008 Read from the filing’s XML Dispute this row
2026-09-15 Filed 2026-09-17ROTE WILLIAM E. Officer: Chief Research Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Common Stock
Acquired (A)39,00025.25
984,750

Derived: shares × price per share. Exact value 984750.00.

154,745Direct (D) Yes
F1
  • F1 Includes 271 shares acquired under the Issuer's 2017 Employee Stock Purchase Plan on May 29, 2026.
Open filing 0001698262-26-000005 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 411

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
VOYA INVESTMENT MANAGEMENT LLC Partly reported under another manager103,235,000 PRN120,421,977 dollarsHigher by 5,050,000 Prior quarter: 98,185,000Open filing 0001068837-26-000006 Filed 2026-11-10 Dispute this row
TENOR CAPITAL MANAGEMENT COMPANY, L.P. 77,733,000 PRN128,849,621 dollarsUnchanged Prior quarter: 77,733,000Open filing 0001346554-26-000092 Filed 2026-11-16 Dispute this row
Context Capital Management, LLC 62,700,000 PRN73,138,547 dollarsHigher by 12,200,000 Prior quarter: 50,500,000Open filing 0001301396-26-000010 Filed 2026-11-04 Dispute this row
BlackRock, Inc. Partly reported under another manager54,275,000 PRN63,175,014 dollarsHigher by 3,550,000 Prior quarter: 50,725,000Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
Calamos Advisors LLC 49,379,000 PRN58,708,668 dollarsHigher by 566,000 Prior quarter: 48,813,000Open filing 0001316507-26-000004 Filed 2026-11-02 Dispute this row
Linden Advisors LP 47,055,000 PRN76,210,098 dollarsHigher by 12,716,000 Prior quarter: 34,339,000Open filing 0001193125-26-462390 Filed 2026-11-16 Dispute this row
Wellesley Asset Management 23,246,000 PRN25,776,903 dollarsLower by 305,000 Prior quarter: 23,551,000Open filing 0001533551-26-000009 Filed 2026-11-12 Dispute this row
LAZARD ASSET MANAGEMENT LLC 18,618,000 PRN248,018 dollarsLower by 1,465,000 Prior quarter: 20,083,000Open filing 0001207017-26-000051 Filed 2026-11-16 Dispute this row
LORD, ABBETT CO. LLC 15,695,000 PRN18,285 dollarsLower by 2,049,000 Prior quarter: 17,744,000Open filing 0000930413-26-003314 Filed 2026-11-13 Dispute this row
Polar Asset Management Partners Inc. 15,500,000 PRN18,229,457 dollarsLower by 15,000,000 Prior quarter: 30,500,000Open filing 0001326389-26-000099 Filed 2026-11-16 Dispute this row
STEELHEAD PARTNERS LLC 15,000,000 PRN17,631,000 dollarsUnchanged Prior quarter: 15,000,000Open filing 0001133521-26-000014 Filed 2026-11-13 Dispute this row
MG PLC Partly reported under another manager14,000,000 PRN16,520,000 dollarsUnchanged Prior quarter: 14,000,000Open filing 0001193125-26-446555 Filed 2026-11-04 Dispute this row
STATE STREET CORP Partly reported under another manager12,700,000 PRN15,043,954 dollarsUnchanged Prior quarter: 12,700,000Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
Janus Henderson Group Ltd. Partly reported under another manager11,891,480 SH700,058,180 dollarsNot in the prior quarter’s filings read Open filing 0001085146-26-000952 Filed 2026-11-16 Dispute this row
AMERIPRISE FINANCIAL INC Partly reported under another manager9,000,000 PRN10,493,356 dollarsLower by 900,000 Prior quarter: 9,900,000Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row
BlackRock, Inc. Partly reported under another manager8,673,231 SH510,679,819 dollarsHigher by 652,568 Prior quarter: 8,020,663Open filing 0002012383-26-003985 Filed 2026-11-13 Dispute this row
FMR LLC Partly reported under another manager5,867,919 SH345,503,077 dollarsLower by 1,228,695 Prior quarter: 7,096,614Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager5,824,254 SH342,932,099 dollarsHigher by 1,255,913 Prior quarter: 4,568,341Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager5,172,000 PRN7,436,886 dollarsHigher by 3,399,000 Prior quarter: 1,773,000Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
BlueCrest Capital Management Ltd 5,000,000 PRN5,944,700 dollarsLower by 1,000,000 Prior quarter: 6,000,000Open filing 0001610880-26-000024 Filed 2026-11-13 Dispute this row
ORBIMED ADVISORS LLC 5,000,000 PRN5,944,700 dollarsUnchanged Prior quarter: 5,000,000Open filing 0001172661-26-005349 Filed 2026-11-16 Dispute this row
MILLENNIUM MANAGEMENT LLC 4,750,000 PRN5,584,645 dollarsUnchanged Prior quarter: 4,750,000Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
SSI INVESTMENT MANAGEMENT LLC Partly reported under another manager4,480,000 PRN5,214,653 dollarsHigher by 4,175,000 Prior quarter: 305,000Open filing 0001172661-26-004930 Filed 2026-11-10 Dispute this row
STATE STREET CORP Partly reported under another manager4,387,309 SH258,324,754 dollarsHigher by 131,085 Prior quarter: 4,256,224Open filing 0000093751-26-000747 Filed 2026-11-12 Dispute this row
VANGUARD CAPITAL MANAGEMENT LLC 4,192,887 SH246,877,187 dollarsHigher by 84,193 Prior quarter: 4,108,694Open filing 0002100119-26-001711 Filed 2026-11-13 Dispute this row
STATE OF WISCONSIN INVESTMENT BOARD 4,058,431 SH8,096,337 dollarsLower by 16,017 Prior quarter: 4,074,448Open filing 0001062993-26-006051 Filed 2026-11-16 Dispute this row
MORGAN STANLEY Partly reported under another manager3,870,000 PRN5,667,588 dollarsHigher by 1,020,000 Prior quarter: 2,850,000Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
PERCEPTIVE ADVISORS LLC 3,542,913 SH208,606,717 dollarsLower by 209,661 Prior quarter: 3,752,574Open filing 0001012975-26-001063 Filed 2026-11-16 Dispute this row
DeepCurrents Investment Group LLC Partly reported under another manager3,300,000 PRN3,906,307 dollarsLower by 4,000,000 Prior quarter: 7,300,000Open filing 0001420506-26-002696 Filed 2026-11-13 Dispute this row
FMR LLC Partly reported under another manager3,072,000 PRN4,592,426 dollarsLower by 100,000 Prior quarter: 3,172,000Open filing 0000315066-26-002964 Filed 2026-11-10 Dispute this row
VANGUARD PORTFOLIO MANAGEMENT LLC 3,040,158 SH179,004,503 dollarsHigher by 1,498,541 Prior quarter: 1,541,617Open filing 0002100121-26-001150 Filed 2026-11-13 Dispute this row
ADVENT CAPITAL MANAGEMENT /DE/ 2,805,000 PRN3,356,824 dollarsLower by 2,669,000 Prior quarter: 5,474,000Open filing 0001140361-26-042650 Filed 2026-11-09 Dispute this row
Jefferies Financial Group Inc. Partly reported under another manager2,567,000 PRN3,043,705 dollarsNot in the prior quarter’s filings read Open filing 0000096223-26-000034 Filed 2026-11-05 Dispute this row
Invesco Ltd. Partly reported under another manager2,500,000 PRN2,909,950 dollarsUnchanged Prior quarter: 2,500,000Open filing 0000914208-26-000462 Filed 2026-11-12 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC Partly reported under another manager2,420,340 SH142,537,650 dollarsHigher by 48,453 Prior quarter: 2,371,887Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
ADAGE CAPITAL PARTNERS GP, L.L.C. 2,410,485 SH141,929,357 dollarsLower by 158,871 Prior quarter: 2,569,356Open filing 0001172661-26-005200 Filed 2026-11-16 Dispute this row
NOMURA ASSET MANAGEMENT INTERNATIONAL INC. Partly reported under another manager2,239,948 SH131,888,138 dollarsLower by 572,566 Prior quarter: 2,812,514Open filing 0000905148-26-004861 Filed 2026-11-16 Dispute this row
Rock Springs Capital Management LP 2,204,085 SH129,776,525 dollarsHigher by 25,016 Prior quarter: 2,179,069Open filing 0001172661-26-005279 Filed 2026-11-16 Dispute this row
Amundi Partly reported under another manager2,200,000 PRN256,076,482 dollarsNot in the prior quarter’s filings read Open filing 0001172661-26-004884 Filed 2026-11-06 Dispute this row
Kynam Capital Management, LP 2,000,000 SH117,760,000 dollarsUnchanged Prior quarter: 2,000,000Open filing 0001907884-26-000017 Filed 2026-11-16 Dispute this row
PRICE T ROWE ASSOCIATES INC /MD/ Partly reported under another manager1,881,534 SH110,786 dollarsHigher by 562,918 Prior quarter: 1,318,616Open filing 0000080255-26-000736 Filed 2026-11-16 Dispute this row
Stephens Investment Management Group LLC 1,876,683 SH110,499,095 dollarsHigher by 1,379 Prior quarter: 1,875,304Open filing 0001314440-26-000017 Filed 2026-11-10 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager1,806,696 SH106,378,291 dollarsHigher by 271,375 Prior quarter: 1,535,321Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
Man Group plc Partly reported under another manager1,590,000 PRN1,876,311 dollarsLower by 260,000 Prior quarter: 1,850,000Open filing 0001637460-26-000004 Filed 2026-11-16 Dispute this row
WELLINGTON MANAGEMENT GROUP LLP Partly reported under another manager1,579,139 SH92,979,703 dollarsHigher by 46,059 Prior quarter: 1,533,080Open filing 0000902219-26-000323 Filed 2026-11-16 Dispute this row
EMERALD ADVISERS, LLC 1,563,532 SH92,060,764 dollarsLower by 37,354 Prior quarter: 1,600,886Open filing 0001104659-26-124249 Filed 2026-11-09 Dispute this row
JPMORGAN CHASE CO Partly reported under another manager1,552,000 PRN1,836,792 dollarsLower by 1,942,000 Prior quarter: 3,494,000Open filing 0000019617-26-000404 Filed 2026-11-12 Dispute this row
Driehaus Capital Management LLC 1,533,171 SH90,273,108 dollarsHigher by 94,037 Prior quarter: 1,439,134Open filing 0000938206-26-000066 Filed 2026-11-16 Dispute this row
Bank of New York Mellon Corp Partly reported under another manager1,399,096 SH16,023,172 dollarsHigher by 902,611 Prior quarter: 496,485Open filing 0001390777-26-000121 Filed 2026-11-05 Dispute this row
ARMISTICE CAPITAL, LLC 1,289,768 SH75,941,540 dollarsLower by 282,771 Prior quarter: 1,572,539Open filing 0001315863-26-000784 Filed 2026-11-16 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • CITADEL ADVISORS LLC 11,750,000 PRN
  • Jupiter Topco LLC 11,324,191 SH
  • D. E. Shaw Co., Inc. 6,500,000 PRN
  • SHENKMAN CAPITAL MANAGEMENT INC 2,250,000 PRN
  • Sixth Street Partners Management Company, L.P. 827,278 SH
  • Capricorn Fund Managers Ltd 321,721 SH
  • Palisades Investment Partners, LLC 273,080 SH
  • UBS Group AG 155,000 PRN
  • ExodusPoint Capital Management, LP 97,442 SH
  • SummitTX Capital, L.P. 96,018 SH
  • 1832 Asset Management L.P. 88,100 SH
  • BNP PARIBAS FINANCIAL MARKETS 85,000 PRN
  • Arrowpoint Investment Partners (Singapore) Pte. Ltd. 55,112 SH
  • Penserra Capital Management LLC 54,216 SH
  • Balyasny Asset Management L.P. 35,385 SH
  • SG Americas Securities, LLC 32,858 SH
  • Jefferies Financial Group Inc. 29,037 SH
  • Verition Fund Management LLC 25,300 SH
  • Squarepoint Ops LLC 11,200 SH
  • FOX RUN MANAGEMENT, L.L.C. 10,940 SH
  • NATIXIS 10,387 SH
  • ADAR1 Capital Management, LLC 10,000 PRN
  • FIFTH THIRD BANCORP 9,000 PRN
  • HIGHLAND CAPITAL MANAGEMENT, LLC 8,701 SH
  • Quantbot Technologies LP 7,851 SH
  • TUDOR INVESTMENT CORP ET AL 5,955 SH
  • Bridgefront Capital, LLC 3,715 SH
  • Marex Group Ltd 3,664 SH
  • Graticule Asia Macro Advisors LLC 3,439 SH
  • Walleye Trading LLC 2,000 SH
  • Walleye Trading LLC 1,901 SH
  • Integrated Wealth Concepts LLC 1,238 SH
  • Pacer Advisors, Inc. 986 SH
  • GROUP ONE TRADING LLC 903 SH
  • Walleye Trading LLC 900 SH
  • CALDWELL SUTTER CAPITAL, INC. 693 SH
  • TORONTO DOMINION BANK 328 SH
  • Federation des caisses Desjardins du Quebec 300 SH
  • Truvestments Capital LLC 144 SH
  • BERTHEL, FISHER COMPANY FINANCIAL SERVICES, INC. 67 SH
  • Institute for Wealth Management, LLC. 67 SH
  • NORTHWESTERN MUTUAL WEALTH MANAGEMENT CO 60 SH
  • Stone House Investment Management, LLC 43 SH
  • Park Place Capital Corp 29 SH
  • Elequin Capital, LP 16 SH
  • Wealth Enhancement Trust Services, Inc. 11 SH
  • Avion Wealth 7 SH
  • CKW FINANCIAL GROUP 7 SH
  • NATIONAL BANK OF CANADA /FI/ 5 SH
  • Trifecta Capital Advisors, LLC 4 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
BANK OF AMERICA CORP /DE/ Common Stock7.16,810,705.0009/30/2026 Filed 2026-11-16SCHEDULE 13G/AAmendment 1Open filing 0000070858-26-000590 Dispute this row
FMR LLC COMMON STOCK6.15,707,883.1509/30/2026 Filed 2026-11-05SCHEDULE 13G/AAmendment 2Open filing 0000315066-26-002862 Dispute this row
Abigail P. Johnson COMMON STOCK6.15,707,883.1509/30/2026 Filed 2026-11-05SCHEDULE 13G/AAmendment 2Open filing 0000315066-26-002862 Dispute this row
Armistice Capital, LLC Common Stock, par value $0.0001 per share1.671,572,539.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-003621 Dispute this row
Steven Boyd Common Stock, par value $0.0001 per share1.671,572,539.0006/30/2026 Filed 2026-08-14SCHEDULE 13G/AAmendment 1Open filing 0001172661-26-003621 Dispute this row
BANK OF AMERICA CORP /DE/ Common Stock5.85,439,155.0006/30/2026 Filed 2026-08-12SCHEDULE 13GOpen filing 0000070858-26-000437 Dispute this row
STATE STREET CORPORATION COMMON STOCK4.64,256,224.0006/30/2026 Filed 2026-08-07SCHEDULE 13GOpen filing 0000093751-26-000546 Dispute this row
FMR LLC COMMON STOCK7.77,142,482.2206/30/2026 Filed 2026-08-06SCHEDULE 13G/AAmendment 1Open filing 0000315066-26-002183 Dispute this row
Abigail P. Johnson COMMON STOCK7.77,142,482.2206/30/2026 Filed 2026-08-06SCHEDULE 13G/AAmendment 1Open filing 0000315066-26-002183 Dispute this row
Armistice Capital, LLC Common Stock, par value $0.0001 per share5.274,897,417.0003/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0001172661-26-002146 Dispute this row
Steven Boyd Common Stock, par value $0.0001 per share5.274,897,417.0003/31/2026 Filed 2026-05-15SCHEDULE 13GOpen filing 0001172661-26-002146 Dispute this row
Vanguard Capital Management Common Stock5.094,699,42403/31/2026 Filed 2026-04-30SCHEDULE 13GOpen filing 0002100119-26-001151 Dispute this row
The Vanguard Group Common Stock0003/13/2026 Filed 2026-03-27SCHEDULE 13G/AAmendment 9Open filing 0000102909-26-002431 Dispute this row
Perceptive Advisors LLC Common Stock, par value $0.0001 per share4.84,278,18012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-054520 Dispute this row
Joseph Edelman Common Stock, par value $0.0001 per share4.84,278,18012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-054520 Dispute this row
Perceptive Life Sciences Master Fund, Ltd. Common Stock, par value $0.0001 per share4.84,278,18012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-054520 Dispute this row
Armistice Capital, LLC Common Stock, par value $0.0001 per share4.213,763,891.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 8Open filing 0001172661-26-001227 Dispute this row
Steven Boyd Common Stock, par value $0.0001 per share4.213,763,891.0012/31/2025 Filed 2026-02-17SCHEDULE 13G/AAmendment 8Open filing 0001172661-26-001227 Dispute this row
Macquarie Group Limited Common Shares0.00012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-049707 Dispute this row
Macquarie Management Holdings Inc Common Shares0.00012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-049707 Dispute this row
Macquarie Investment Management Business Trust Common Shares0.00012/31/2025 Filed 2026-02-13SCHEDULE 13G/AAmendment 1Open filing 0001193125-26-049707 Dispute this row
STATE STREET CORPORATION COMMON STOCK5.34,756,666.0012/31/2025 Filed 2026-02-09SCHEDULE 13GOpen filing 0000093751-26-000092 Dispute this row
FMR LLC COMMON STOCK11.710,567,302.7812/31/2025 Filed 2026-01-08SCHEDULE 13GOpen filing 0000315066-26-000051 Dispute this row
Abigail P. Johnson COMMON STOCK11.710,567,302.7812/31/2025 Filed 2026-01-08SCHEDULE 13GOpen filing 0000315066-26-000051 Dispute this row
Perceptive Advisors LLC Common Stock, par value $0.0001 per share5.54,895,61510/06/2025 Filed 2025-10-14SCHEDULE 13GOpen filing 0001193125-25-238357 Dispute this row
Joseph Edelman Common Stock, par value $0.0001 per share5.54,895,61510/06/2025 Filed 2025-10-14SCHEDULE 13GOpen filing 0001193125-25-238357 Dispute this row
Perceptive Life Sciences Master Fund, Ltd. Common Stock, par value $0.0001 per share5.54,895,61510/06/2025 Filed 2025-10-14SCHEDULE 13GOpen filing 0001193125-25-238357 Dispute this row
JANUS HENDERSON GROUP PLC Common Stock11.910,599,66009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 2Open filing 0001274173-25-000318 Dispute this row
Armistice Capital, LLC Common Stock, par value $0.0001 per share7.526,724,000.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 7Open filing 0001172661-25-005160 Dispute this row
Steven Boyd Common Stock, par value $0.0001 per share7.526,724,000.0009/30/2025 Filed 2025-11-14SCHEDULE 13G/AAmendment 7Open filing 0001172661-25-005160 Dispute this row
JANUS HENDERSON GROUP PLC Common Stock12.811,339,86407/31/2025 Filed 2025-08-07SCHEDULE 13G/AAmendment 1Open filing 0001274173-25-000194 Dispute this row
Armistice Capital, LLC Common Stock, par value $0.0001 per share9.968,876,000.0006/30/2025 Filed 2025-08-15SCHEDULE 13G/AAmendment 6Open filing 0001172661-25-003635 Dispute this row
Steven Boyd Common Stock, par value $0.0001 per share9.968,876,000.0006/30/2025 Filed 2025-08-15SCHEDULE 13G/AAmendment 6Open filing 0001172661-25-003635 Dispute this row
The Vanguard Group Common Stock6.745,994,28306/30/2025 Filed 2025-07-29SCHEDULE 13G/AAmendment 9Open filing 0000932471-25-001051 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,762,359 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015178,741
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to TRAVERE THERAPEUTICS, INC.